Publications

Wheeler MW, Bailer AJ. 2009. Benchmark dose estimation incorporating multiple data sources. Risk Anal 29(2):249-56; doi: 10.1111/j.1539-6924.2008.01144x. PMID: 19000080.

Sacks NC. 2009. Healthcare spending among privately insured individuals under age 65. IMS Health, February.

Thompson CM, Johns DO, Sonawane S, Barton HA, Hattis D, Tardif R, Krishnan K. 2009. Database for physiologically based pharmacokinetic (PBPK) modeling: Physiological parameters for healthy and health-impaired elderly. J Toxicol Environ Health B 12(1):1–24; doi: 10.1080/10937400802545060. PMID: 19117207.

Clewell RA, Kremer JJ, Williams CC, Campbell JL, Sochaski MA, Andersen ME, Borghoff SJ. 2009. Kinetics of selected di-n-butyl phthalate metabolites and fetal testosterone following repeated and single administration in pregnant rats. Toxicology 255(1–2):80–90; doi: 10.1016/j.tox.2008.10.010. PMID: 19010379.

Williams CW, Perry CS. Risk assessment for arsenic on indoor surfaces. Presented at the Society for Risk Analysis Annual Meeting, Boston, MA, December 2008.

Luo W, Nordstrom BL, Fraeman K, Nordyke RJ, Ranganathan G, Linz HE, Winterkorn A, Stokes M, et al. 2008. Adherence to guidelines for use of ESAs in patients with chemotherapy-induced anemia: Results of a retrospective study of an EMR database in the US, 2002-2006. Clin Ther 30(12):2423-35; doi: 10.1016/j.clinthera.2008.12.022. PMID: 19167601.

Makris SL, Thompson CM, Euling SY, Selevan SG, Sonawane B. 2008. A lifestage-specific approach to hazard and dose-response characterization for children’s health risk assessment. Birth Defects Res B 83(6):530–546; doi: 10.1002/bdrb.20176. PMID: 19085945.

Thompson CM, Subramaniam RP, Grafström RC. 2008. Mechanistic and dose considerations for supporting adverse pulmonary physiology in response to formaldehyde. Toxicol Appl Pharmacol 233(3):355–359; doi: 10.1016/j.taap.2008.09.011. PMID: 18851987.

Wagner ME, Travis LB. 2008. Letter to the editor re: “Mesothelioma and asbestos.” Regul Toxicol Pharmacol 52(3):353–354 (author reply, 355); doi: 10.1016/j.yrtph.2008.07.001. PMID: 18680780.

Proctor D. 2008. Hexavalent chromium. In: Encyclopedia of Quantiative Risk Analysis and Assessment, Melnick E, Everitt B. (eds.). Wiley.

Harris MA, Shay E, Unice KM, Scott LF, Haws LC. Preliminary evaluation of health risks posed by PCDD/Fs and PCBs from the ingestion of fish from the Lower Passaic River. Presented at Dioxin 2008, Birmingham, England, August 2008.

Covington TR, Gearhart JM, Jakubowski EM, McGuire JM, Evans RA, Hulet SW. Physiologically-based pharmacokinetic/pharmacodynamic (PBPK/PD) modeling of VX exposure through various routes to multiple species. Poster presented at the Chemical and Biological Defense Physical Science and Technology Conference, New Orleans, LA, November 2008.

Garabrant DH, Hong B, Chen Q, Chang C-W, Jiang X, Franzblau A, Lepkowski J, Adriaens P, et al. 2008. Factors that predict serum PCB, PCDD, and PCDF concentrations in Michigan, USA. Epidemiology 19(6):S265; doi: 10.1097/01.ede.0000340275.84909.26.

Nordstrom BL, Weixiu L, Fraeman KH, Whyte JL, Nordyke RJ. 2008. Use of erythropoiesis-stimulating agents among chemotherapy patients with hemoglobin exceeding 12 grams per deciliter. J Manag Care Pharm 14(9):858-69; doi: 10.18553/jmcp.2008.14.9.858. PMID: 19006442.

Harris MA, Tachovsky JA, Williams ES, Paustenbach DP, Haws LC. Assessment of the health risks posed by benzene in soft drinks. Presented at the Society of Toxicology 47th Annual Meeting, Seattle, WA, March 2008.

Patlewicz G, Worth A. 2008. Review of Data Sources, QSARs and Integrated Testing Strategies for Skin Sensitization. EUR 23225 EN.

Teeguarden JG, Bogdanffy MS, Covington TR, Tan C, Jarabek AM. 2008. A PBPK model for evaluating the impact of aldehyde dehydrogenase polymorphisms on comparative rat and human nasal tissue acetaldehyde dosimetry. Inhal Toxicol 20(4):375–390; doi: 10.1080/08958370801903750.

Ulrich K, Hincks JS, Walsh R, Caroline Wetterstrand EM, Fidock MD, Sreckovic S, Lamb DJ, Douglas GJ, Yeadon M, Perros-Huguet C, Evans SM. 2008. Anti-inflammatory modulation of chronic airway inflammation in the murise house dust mite model. Pulmon Pharmacol Therapeut 21(4):637–647; doi: 10.1016/j.pupt.2008.02.006.

Robison TW. Toxicology in the nonclinical development of drugs and biologics. Pharmaceutical Education and Research Institute, Genetic Toxicology, Arlington, VA, September 2008.

James HR, Barfield L, Britt JK, James RC. 2008. Worker exposure to secondhand smoke: Evaluating a prediction model. Prof Saf Sep:34-44.